BioAge Labs, Inc.
BIOA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $216 | $220 | $257 | $354 |
| Short-Term Investments | $70 | $77 | $63 | $0 |
| Receivables | $1 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $4 | $4 | $3 |
| Total Curr. Assets | $291 | $302 | $325 | $357 |
| Property Plant & Equip (Net) | $4 | $4 | $4 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $16 | $15 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $10 | $0 | $0 | $0 |
| Total NC Assets | $14 | $20 | $19 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $305 | $322 | $344 | $358 |
| Liabilities | – | – | – | – |
| Payables | $5 | $1 | $4 | $2 |
| Short-Term Debt | $5 | $6 | $7 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $8 | $8 | $8 | $8 |
| Other Curr. Liab. | $7 | $8 | $5 | $12 |
| Total Curr. Liab. | $24 | $23 | $24 | $28 |
| LT Debt | $2 | $3 | $4 | $3 |
| Deferred Rev, NC | $0 | $2 | $3 | $5 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $5 | $7 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $3 | $3 | $0 |
| Total Liabilities | $28 | $27 | $31 | $35 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$307 | -$287 | -$266 | -$253 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $585 | $582 | $579 | $576 |
| Total Equity | $277 | $295 | $313 | $323 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $305 | $322 | $344 | $358 |
| Net Debt | -$208 | -$212 | -$247 | -$346 |